GeNeuro in-licensed its initial technology from bioMérieux and INSERM. GeNeuro’s technology is protected by a portfolio of patents representing 17 patent families (16 in HERV-W and 1 in HERV-K), covering sequences, products and particular applications. Based on more than 25 years of work in the area and a systematic effort to optimize and develop intellectual property, GeNeuro believes that its intellectual property portfolio and its constant efforts to protect new discoveries put the Company in a strong competitive position.

HERV-W: 16 families of patents covering the following three broad categories